-
Sun Pharma Wins Interim Relief in NAXDOM Trademark Row, Delhi HC Bars Alenvision's NEXADOM Drug
13 Oct 2025 22:36 GMT
… had earlier cautioned in the Cadila Healthcare case. Sun Pharma also cited … agents from manufacturing, selling, or advertising medicines under the mark NEXADOM … manufacturing, selling, offering for sale, advertising, directly or indirectly dealing in …
-
India API Market to Reach USD 37.11 Billion by 2032 | CAGR 12.33%
23 Sep 2025 12:16 GMT
India's Active Pharmaceutical Ingredients (API) market is projected to grow from USD 13.03 billion in 2023 to USD 37.11 billion by 2032.
INDORE, INDIA, September 23, 2025 /EINPresswire.com/ -- India's Active Pharmaceutical Ingredients ( …
-
Zydus Cadila Healthcare Therapeutic and Drug Pipeline Review H2
01 Feb 2017 06:33 GMT
Zydus Cadila Healthcare Treatment Pipeline Review H2 2017
PUNE, INDIA, February 1, 2017 /EINPresswire.com/ -- Zydus Cadila Healthcare Ltd - Product Pipeline Review - 2016
Summary
The report provides comprehensive information on the …
-
Proton Pump Inhibitors Market to Surpass Valuation of USD 7.35 Billion by 2031 | SkyQuest Technology
25 Nov 2024 09:51 GMT
Westford, USA, Nov. 25, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global proton pump inhibitors market size will reach a value of USD 7.35 Billion by 2031, with a CAGR of 5.2% during the forecast period (2024-2031). There is an increasing demand …
-
Epilepsy Treatment Market Anticipates Reaching a Valuation of $14.7 Billion by 2033, Propelled by a Robust CAGR of 7.7%, according to projections by Persistence Market Research
11 Jan 2024 07:00 GMT
New York, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The global epilepsy treatment market revolves around the management and treatment of epilepsy, a neurological disorder characterized by recurrent seizures. Over the years, advancements in understanding the …
-
Advancements in the Production Capabilities of Patented Chemicals Drive Specialty Active Pharmaceutical Ingredient Market | Future Market Insights, Inc.
09 Nov 2023 12:00 GMT
NEWARK, Del, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The worldwide demand for specialty active pharmaceutical ingredient market was valued at US$ 196.8 billion in 2022. The overall market is anticipated to increase at a CAGR of 3.2% through 2033. This market …
-
Peptic Ulcer Drugs Market Projected to Surge to US$59.2 Billion by 2033, Fueled by OTC Adoption and Phytotherapy Emergence: Report by Persistence Market Research
25 Oct 2023 08:39 GMT
New York, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The global peptic ulcer drugs market size was USD 40.0 billion in 2022 and is projected to grow from USD 41.2 billion in 2023 to USD 59.2 billion in 2023 at a CAGR of 3.7% during the forecast period. Peptic ulcer …
-
Oral Rehydration Solution [ORS] Market to Exceed USD 6.71 billion by 2031, Capturing a 9.9% CAGR: TMR Report
05 Oct 2023 10:58 GMT
Wilmington, Delaware, United States, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The oral rehydration solution (ORS) market acquired US$ 2.55 billion in 2021. The market is anticipated to reach US$ 6.71 billion by 2031 expanding …
-
China Medical System: New Drug Application of Desidustat Tablets Accepted in China
23 Apr 2024 13:46 GMT
… Lifesciences Limited (earlier known as Cadila Healthcare Limited) on 20 January 2020 … you and is not for advertising purposes. This press release does …
-
Opioids Market Size is projected to reach USD 32.25 billion by 2031, growing at a CAGR of 1.95%: Straits Research
29 Jun 2023 15:10 GMT
New York, United States, June 29, 2023 (GLOBE NEWSWIRE) -- Opioids are medications used to treat severe or persistent pain, such as chronic headaches and backaches, by patients recovering from surgery or experiencing severe pain associated with cancer, as …
About
© 1995-2025